Pemetrexed dipotassium formulations
AssigneeShilpa Medicare Limited
InventorsPradeep Shivakumar, Akshay Kant Chaturvedi
Life of this patent
Estimating the term…
Abstract
The present application provides pharmaceutical compositions derived from pemetrexed dipotassium Nonahydrate and its process thereof. The present application also provides a method of treating cancer by administering intravenously the reconstituted lyophilized compositions into a patient in need thereof.
Claims1
A pharmaceutical composition comprising pemetrexed dipotassium nonahydrate characterized by X-ray powder diffraction pattern containing at least 5 characteristic 2θ° diffraction angle peaks selected from the XRPD peak set of 5.0, 12.5, 17.2, 20.8, 22.4, 25.7, 26.9 and 27.9±0.20 2θ°, and a pharmaceutically acceptable amount of an excipient, wherein the pharmaceutical composition having moisture content less than 2% w/w.
Dependencies are inferred from the claim text.